For patients with advanced metabolic dysfunction, fatty liver disease, or those seeking maximal weight loss, retatrutide may become the gold standard therapy offering results previously only attainable through surgery
doi: 10.3389/fendo.2021.622737 51 MorettoTMiltonDRidgeTMacconellLOkersonTWolkaAet al
Altered regulation of iron metabolism has been shown to play a role in the pathogenesis of HCC, particularly in patients who present with NASH, hemochromatosis, or thalassemia [91, 92]
Aldose reductase (AR) and glutathione reductase (GR) compete for the cofactor NADPH, which results in a decrease in GSH levels, as well as increased OS
Pan J, Liu H, Wu Q, Zhou M